The Ramlilas in the city are always traditional. Yet they also embrace modernity every year. This year, they are stepping ...
On Tuesday, Tencent released HunyuanWorld-Voyager, a new open-weights AI model that generates 3D-consistent video sequences from a single image, allowing users to pilot a camera path to "explore" ...
Horizon Worlds is a virtual reality social platform launched by Meta, allowing users to create and share their own virtual worlds. With ongoing technological advancements, Meta introduced a preview ...
Vatican’s historic concert blends genres from hip-hop to classical, signaling a new era of openness and engagement ...
The Horizon Studio desktop editor is an application designed specifically for Windows tablet devices, marking a significant upgrade in Meta's virtual creation tools. Earlier this year in February, ...
Leading researchers, medical professionals, and industry experts gathered in Shanghai on Friday for the fourth smart ...
Creative Bloq on MSN
What's new in Godot 4.5? Everything you need to know
Top of the list of new Godot 4.5 features is stencil buffer support. Like the existing depth buffer, a stencil buffer provides a memory buffer that meshes can write to for later comparison, but it ...
WASHINGTON – The Republican-controlled House of Representatives voted on party lines on Aug. 3 to create a special panel to reinvestigate the events of the Jan. 6, 2021 insurrection. In 2022, after 18 ...
The Mountaineer Mantrip and the singing of "Take Me Home, Country Roads" are two traditions that mean a lot to West Virginia fans, coaches, and players. During the football team's opener last week ...
Crime Scene Zero is ready to take Korean variety shows to the next level, with its official premiere on Netflix set for September 23, 2025.
A renowned sculptor who will create a statue of Queen Elizabeth II for her national memorial said he wants to craft a ...
Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results